# BIO-INT-004 security review — Zainab round 6

**Verdict: PASS**  
**Reviewed head:** `6850f78`  
**Acceptance remediation:** `94c42be`

## Assessment

The acceptance remediation introduces no new security blocker:

- Production changes to `WebhookSubscriptionsPanel.tsx` are test selectors only. They do not
  change tenant context, authorization, destination validation, signing-secret generation,
  persistence, or delivery behavior.
- The new simulation-mode Playwright coverage exercises list, create, one-time secret display,
  empty-selection prevention, and both enable/disable transitions through the existing service
  ports. It does not weaken or replace the backend permission boundary.
- The `/settings/authentication` exclusion is documented explicitly and is coherent: webhook
  subscription management remains on `/administration/integrations` and does not add an
  authentication-settings route.
- The merged `develop` content is unrelated already-reviewed work; the BIO-INT-004 security
  controls passed in round 5 remain unchanged.

## Verification

- Inspected the complete `33b9c42..6850f78` delta and isolated the acceptance-specific production
  change at `94c42be` from the `develop` merge.
- Reviewed the new five-case Playwright specification and committed execution transcript.
- Builder evidence records 5/5 Playwright cases passing twice, 244/244 integration tests, and
  210/210 unit tests.
- An independent Playwright rerun could not start its local server because the managed sandbox
  denied binding `127.0.0.1:3000` with `EPERM`; this is an environment restriction, not a test
  failure.
